|
[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
|
[2]YANG BH, ZHANG BH.Risk factors and prevention for primary liver cancer[J].J Clin Hepatol, 2012, 28 (4) :253-258. (in Chinese) 杨秉辉, 张博恒.重视肝癌的病因和预防[J].临床肝胆病杂志, 2012, 28 (4) :253-258.
|
|
[3]MORALES M, CABRERA MA, MAESO MD, et al.Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas:a case report[J].Oncol Lett, 2013, 5 (3) :969-971.
|
|
[4]FINN OJ.Immune response as a biomarker for cancer detection and a lot more[J].N Engl J Med, 2005, 353 (12) :1288-1290.
|
|
[5]LI J, WANG LJ, YING X, et al.Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer[J].Scand J Immunol, 2012, 75 (3) :342-349.
|
|
[6]BALDWIN RW.Immunity to transplanted tumour:the effect of tumour extracts on the growth of homo-logous tumours in rats[J].Br J Cancer, 1955, 9 (4) :646-651.
|
|
[7]BELOUSOV PV, KUPRASH DV, NEDOSPASOV SA, et al.Autoantibodies to tumor-associated antigens as cancer biomarkers[J].Curr Mol Med, 2010, 10 (2) :115-122.
|
|
[8]LOILOME W, YOOYUEN S, NAMWAT N, et al.PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangio carcinoma:application for assessment of the risk group[J].Tumour Biol, 2012, 33 (6) :2289-2298.
|
|
[9]SPIOTTO MT, RETH MA, SCHREIBER H.Genetic changes occurring in established tumors rapidly stimulate new antibody responses[J].Proc Natl Acad Sci U S A, 2003, 100 (9) :5425-5430.
|
|
[10]CASIANO CA, MEDIAVILLA-VARELA M, TAN EM.Tumor-associated antigen arrays for the serological diagnosis of cancer[J].Mol Cell Proteomics, 2006, 5 (10) :1745-1759.
|
|
[11]ANDERSON KS, LABAER J.The sentinel within:exploiting the immune system for cancer biomarkers[J].J Proteome Res, 2005, 4 (4) :1123-1133.
|
|
[12]BEI R, MASUELLI L, PALUMBO C, et al.A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients:inflammation in their induction and impact on tumor growth[J].Cancer Lett, 2009, 281 (1) :8-23.
|
|
[13]LUNA CORONELL JA, SYED P, SERGELEN K, et al.The current status of cance biomarker research using tumour-associated antigens for minimal invasive and earlycancer diagnostics[J].J Proteomics, 2012, 76:102-115.
|
|
[14]SUZUKI A, IIZUKA A, KOMIYAMA M, et al.Identification of melanoma antigens using a Serological Proteome Approach (SERPA) [J].Cancer Genomics Proteomics, 2010, 7 (1) :17-23.
|
|
[15] BABEL I, BARDE RAS R, DIAZ-URIARTE R, et al.Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays[J].Mol Cell Proteomics, 2009, 8 (10) :2382-2395.
|
|
[16]KOBAYASHI S, KIM SR, IMOTO S, et al.Histopathological diagnosis of early HCC through biopsy:efficacy of victoria blue and cytokeratin 7 staining[J].Dig Dis, 2012, 30 (6) :574-579.
|
|
[17]NIE RH, LIU YY.Application of detection of tumor markers AFP, CA125, CA199 and CEA in diagnosis and treatment for patients with hepatitis and liver cirrhosis[J].J Jilin Univ:Med Edit, 2012, 38 (1) :119-122. (in Chinese) 聂荣慧, 刘元元.肿瘤标志物AFP、CA125、CA199和CEA检测在肝炎、肝硬化患者诊断和治疗中的应用[J].吉林大学学报:医学版, 2012, 38 (1) :119-122.
|
|
[18]ZHANG WP.Alpha-fetoprotein and liver cancer:a new understanding of an old problem[J].J Med Res, 2013, 42 (6) :3-5. (in Chinese) 章卫平.甲胎蛋白与肝癌:老问题的新认识[J].医学研究杂志, 2013, 42 (6) :3-5.
|
|
[19] ERTLE JM, HEIDER D, WICHERT M, et al.A Combination ofα-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma[J].Digestion, 2013, 87 (2) :121-131.
|
|
[20]MATSUBARA M, SHIRAHA H, KATAOKA J, et al.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2012, 27 (10) :1602-1608.
|
|
[21]CHOI JY, JUNG SW, KIM HY, et al.Diagnostic value of AFP-L3and PIVKA-II in hepatocellular carcinoma according to total-AFP[J].World J Gastroenterol, 2013, 19 (3) :339-346.
|
|
[22]YANG Y, XIA T, LI N, et al.Combined effects of p53 and MDM2polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma[J].Protein Cell, 2013, 4 (1) :71-81.
|
|
[23]LU M, NAKAMURA RM, DENT ED, et al.Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis[J].Am J Pathol, 2001, 159 (3) :945-953.
|
|
[24]TAKASHIMA M, KURAMITSUY, YOKOYAMAY, et al.Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma[J].Proteomics, 2006, 6 (13) :3894-3900.
|
|
[25]STENNER-LIEWEN F, LUO G, SAHIN U, et al.Definition of tumor-associated antigens in hepatocellular carcinoma[J].Cancer Epidemiol Biomarkers Prev, 2000, 9 (3) :285-290.
|
|
[26]UEMURA M, NOUSO K, KOBAYASHI Y, et al.Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma[J].Cancer, 2003, 97 (10) :2474-2479.
|
|
[27]LI L, CHEN SH, YU CH, et al.Identification of hepatocellularcarcinoma-associate dantigens and autoantibodies by serological proteome analysis combined with protein microarray[J].J Proteome Res, 2005, 7 (2) :611-620.
|
|
[28]ZOU L, WU Y, PEI L, et al.Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis[J].Leuk Res, 2005, 29 (12) :1387-1391.
|
|
[29]CHEN Y, ZHOU Y, QIU S, et al.Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma[J].Cancer Lett, 2010, 289 (1) :32-39.
|
|
[30]LI Y, WANG K, DAI L, et al.HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility[J].Oncol Lett, 2012, 4 (2) :358-364.
|
|
[31]SHAO Q, REN P, LI Y, et al.Autoantibodies against glucoseregulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma[J].Int J Oncol, 2012, 41 (3) :1061-1067.
|
|
[32]AKADA J, KAMEI S, ITO A, et al.A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients[J].Proteome Sci, 2013, 11 (1) :33.
|
|
[33]NAHON P, SUTTON A, RUFAT P, et al.Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis[J].Hepatology, 2009, 50 (5) :1484-1493.
|
|
[34]TAN Y, QIN S, HOU X, et al.Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma[J].Curr Pharm Des, 2014, 20 (1) :81-87.
|
DownLoad: